Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 47 results.
User Information
Export Records
  1. 1.   TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells
  2. Kundu, Manjari; Greer, Yoshimi E; Lobanov, Alexei; Ridnour, Lisa; Donahue, Renee N; Ng, Yeap; Ratnayake, Shashi; White, Karley; Voeller, Donna; Weltz, Sarah; Chen, Qingrong; Lockett,Stephen; Cam, Maggie; Meerzaman, Daoud; Wink, David A; Weigert, Roberto; Lipkowitz, Stanley
  3. Cancer Letters. 2025, Jun 28; 620: 217692.
  1. 2.   Association ofTNFRSF1BPromoter Polymorphisms with Human Disease: Further Studies Examining T-Regulatory Cells Are Required
  2. Li, Hongchuan; Anderson, Steve
  3. Frontiers in immunology. 2018, Mar 6; 9: 443.
  1. 3.   TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. Current directions in autoimmunity. 2010 11: 119-34.
  1. 4.   Development of a cell-based assay to quantify the inflammatory potential of test substances and screen compound libraries for anti-cancer drug candidates in a high-throughput format
  2. Kozlov, S. V.
  3. Methods in molecular biology (Clifton, N.J.). 2009 512: 159-167.
  1. 5.   TNF polymorphisms and prostate cancer risk
  2. Danforth, K. N.; Rodriguez, C.; Hayes, R. B.; Sakoda, L. C.; Huang, W. Y.; Yu, K.; Calle, E. E.; Jacobs, E. J.; Chen, B. E.; Andriole, G. L.; Figueroa, J. D.; Yeager, M.; Platz, E. A.; Michaud, D. S.; Chanock, S. J.; Thun, M. J.; Hsing, A. W.
  3. Prostate. 2008 68(4): 400-407.
  1. 6.   Tumor necrosis factor is critical to control tuberculosis infection
  2. Jacobs, M.; Togbe, D.; Fremond, C.; Samarina, A.; Allie, N.; Botha, T.; Carlos, D.; Parida, S. K.; Grivennikov, S.; Nedospasov, S.; Monteiro, A.; Le Bert, M.; Quesniaux, V.; Ryffel, B.
  3. Microbes and Infection. 2007, Apr; 9(5): 623-628.
  1. 7.   Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors
  2. Oguariri, R. M.; Brann, T. W.; Imamichi, T.
  3. Journal of Biological Chemistry. 2007, Feb; 282(6): 3594-3604.
  1. 8.   Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity
  2. Brown, E. E.; Fallin, D.; Ruczinski, I.; Hutchinson, A.; Staats, B.; Vitale, F.; Lauria, C.; Serraino, D.; Rezza, G.; Mbisa, G.; Whitby, D.; Messina, A.; Goedert, J. J.; Chanock, S. J.; Kaposi Sarcoma Working, G.
  3. Cancer Epidemiology Biomarkers & Prevention. 2006, May; 15(5): 926-934.
  1. 9.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 10.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 11.   A transcription inhibitor, Actinomycin D, enhances HIV-1 replication through an interleukin-6-dependent pathway
  2. Imamichi, T.; Conrads, T. P.; Zhou, M.; Liu, Y. X.; Adelsberger, J. W.; Veenstra, T. D.; Lane, H. C.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 1; 40(4): 388-397.
  1. 12.   Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice
  2. Drutskaya, M. S.; Ortiz, M.; Liepinsh, D. J.; Kuprash, D. V.; Nedospasov, S. A.; Keller, J. R.
  3. Experimental Hematology. 2005, NOV; 33(11): 1348-1356.
  1. 13.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 14.   Phosphorylation of Ser(24) in the pleckstrin homology domain of insulin receptor substrate-1 by mouse Pelle-like kinase/interleukin-1 receptor-associated kinase - Cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance
  2. Kim, J. A.; Yeh, D. C.; Ver, M.; Li, Y. H.; Carranza, A.; Conrads, T. P.; Veenstra, T. D.; Harrington, M. A.; Quon, M. J.
  3. Journal of Biological Chemistry. 2005, JUN 17; 280(24): 23173-23183.
  1. 15.   Coactivators and corepressors of NF-kappa B in I kappa Beta alpha gene promoter
  2. Gao, Z. G.; Chiao, P.; Zhang, X.; Zhang, X. H.; Lazar, M. A.; Seto, E.; Young, H. A.; Ye, J. P.
  3. Journal of Biological Chemistry. 2005, JUN 3; 280(22): 21091-21098.
  1. 16.   Novel tumor necrosis factor-knockout mice that lack Peyer's patches
  2. Kuprash, D. V.; Tumanov, A. V.; Liepinsh, D. J.; Koroleva, E. P.; Drutskaya, M. S.; Kruglov, A. A.; Shakhov, A. N.; Southon, E.; Murphy, W. J.; Tessarollo, L.; Grivennikov, S. L.; Nedospasov, S. A.
  3. European Journal of Immunology. 2005, MAY; 35(5): 1592-1600.
  1. 17.   Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis
  2. Brooks, A. D.; Sayers, T. J.
  3. Cancer Immunology Immunotherapy. 2005, MAY; 54(5): 499-505.
  1. 18.   Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages
  2. Cho, H.; Lasco, T. M.; Allen, S. S.; Yoshimura, T.; McMurray, D. N.
  3. Infection and Immunity. 2005, MAR; 73(3): 1367-1376.
  1. 19.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 20.   TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells
  2. Herbeuval, J. P.; Boasso, A.; Grivel, J. C.; Hardy, A. W.; Anderson, S. A.; Dolan, M. J.; Chougnet, C.; Lifson, J. D.; Shearer, G. M.
  3. Blood. 2005 105(6): 2458-2464.
  1. 21.   Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines
  2. Krakauer, T.; Chen, X.; Howard, O. M. Z.; Young, H. A.
  3. Immunopharmacology and Immunotoxicology. 2005 27(1): 53-66.
  1. 22.   Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: Protective and deleterious effects
  2. Grivennikov, S. I.; Tumanov, A. V.; Liepinsh, D. J.; Kruglov, A. A.; Marakusha, B. I.; Shakhov, A. N.; Murakami, T.; Drutskaya, L. N.; Forster, I.; Clausen, B. E.; Tessarollo, L.; Ryffel, B.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunity. 2005, JAN; 22(1): 93-104.
  1. 23.   Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages
  2. Skwor, T. A.; Cho, H. S.; Cassidy, C.; Yoshimura, T.; McMurray, D. N.
  3. Journal of Leukocyte Biology. 2004, DEC; 76(6): 1229-1239.
  1. 24.   BCL-3 and NF-kappa B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages
  2. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2004, NOV 26; 279(48): 49995-50003.
  1. 25.   Anti-interleukin-12 antibody for active Crohn's disease
  2. Mannon, P. J.; Fuss, I. J.; Mayer, L.; Elson, C. O.; Sandborn, W. J.; Present, D.; Dolin, B.; Goodman, N.; Groden, C.; Hornung, R. L.; Quezado, M.; Neurath, M. F.; Salfeld, J.; Veldman, G. M.; Schwertschlag, U.; Strober, W.
  3. New England Journal of Medicine. 2004, NOV 11; 351(20): 2069-2079.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel